CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,321,016 | +37.7% | 3,307,915 | +1.1% | 0.02% | +47.1% |
| Q2 2023 | $35,828,487 | +27.4% | 3,272,008 | +1.5% | 0.02% | +21.4% |
| Q1 2023 | $28,120,797 | +19318.0% | 3,224,862 | +13862.3% | 0.01% | – |
| Q4 2022 | $144,818 | +78.8% | 23,097 | 0.0% | 0.00% | – |
| Q3 2022 | $81,000 | +12.5% | 23,097 | -5.6% | 0.00% | – |
| Q2 2022 | $72,000 | -8.9% | 24,464 | -3.9% | 0.00% | – |
| Q1 2022 | $79,000 | -24.0% | 25,452 | -17.5% | 0.00% | – |
| Q4 2021 | $104,000 | -75.1% | 30,833 | -73.0% | 0.00% | – |
| Q3 2021 | $417,000 | +334.4% | 114,218 | +419.1% | 0.00% | – |
| Q2 2021 | $96,000 | -4.0% | 22,003 | 0.0% | 0.00% | – |
| Q1 2021 | $100,000 | -21.3% | 22,003 | -0.9% | 0.00% | – |
| Q4 2020 | $127,000 | -22.1% | 22,210 | -1.2% | 0.00% | – |
| Q3 2020 | $163,000 | -90.4% | 22,487 | -98.0% | 0.00% | -100.0% |
| Q1 2020 | $1,704,000 | -24.5% | 1,151,356 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,257,000 | -61.7% | 1,151,356 | 0.0% | 0.00% | -66.7% |
| Q3 2019 | $5,895,000 | -28.5% | 1,151,356 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $8,244,000 | -44.7% | 1,151,356 | +2.5% | 0.00% | -50.0% |
| Q1 2019 | $14,917,000 | +9.3% | 1,123,256 | -35.2% | 0.01% | 0.0% |
| Q4 2018 | $13,647,000 | -29.0% | 1,734,100 | 0.0% | 0.01% | -20.0% |
| Q3 2018 | $19,214,000 | -20.4% | 1,734,100 | -3.6% | 0.01% | -16.7% |
| Q2 2018 | $24,139,000 | +3.3% | 1,798,700 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $23,365,000 | +75.3% | 1,798,700 | +24.2% | 0.01% | +100.0% |
| Q4 2017 | $13,328,000 | +10.2% | 1,448,700 | -3.4% | 0.01% | 0.0% |
| Q3 2017 | $12,090,000 | – | 1,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |